TrialCNS drugs2025

Subclinical Augmentation in Relation to Previous Dopaminergic Treatment in Patients with Restless Legs Syndrome: A Post Hoc Analysis of Two Randomized, Placebo-Controlled, Crossover Trials.

Diego Garcia-Borreguero et al.PubMed ↗Publisher ↗

No numbers read from the abstract.